Improvement of cytokine response and survival time by bioartificial kidney therapy in acute uremic pigs with multi-organ dysfunction

International Journal of Artificial Organs

Volumn 33, Issue 8, 2010, Pages 526-534

  Wang, Hengjin ^a   Zhang, Miao ^a,b   Wang, Xiaoyun ^b   Mao, Huijuan ^b   Ying, Xumin ^b   Zhu, Wenbin ^c   Sun, Cheng ^a   Jiang, Chunming ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Bioartificial renal tubule; Interleukin 10; Multiple organ dysfunction syndrome; Survival time; Tumor necrosis factor

Indexed keywords

BODY FLUIDS; MAMMALS;

BIOARTIFICIAL; BIOARTIFICIAL RENAL TUBULE; CYTOKINE RESPONSE; INTERLEUKIN-10; MULTIPLE ORGAN DYSFUNCTION SYNDROME; RENAL TUBULE; SURVIVAL TIME; TNF Α; TUMOR NECROSE FACTOR-Α; TUMOR NECROSIS FACTORS;

BLOOD PRESSURE;

ENDOTOXIN; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL HYBRIDIZATION; ARTIFICIAL KIDNEY; BLOOD GAS; BLOOD PRESSURE; CONTROLLED STUDY; CYTOKINE RESPONSE; EXPERIMENTAL PIG; HEMOFILTRATION; KIDNEY FUNCTION; LIVER FUNCTION; MEAN ARTERIAL PRESSURE; MULTIPLE ORGAN FAILURE; NONHUMAN; PROTEIN BLOOD LEVEL; SURVIVAL TIME; UREMIA;

EID: 77957848180     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139881003300803     Document Type: Article

References (25)

1. Crowley ST, Peixoto AJ. Acute kidney injury in the intensive care unit. Clin Chest Med 2009; 30: 29-43.
2. Issa N, Messer J, Paganini EP. Renal assist device and treatment of sepsis-induced acute kidney injury in intensive care units. Contrib Nephrol 2007;156: 419-27.
3. Tumlin J, Wali R, Williams W, et al. Efficacy and safety of renal tubule cell therapy for acute renal failure. J Am Soc Nephrol 2008; 19: 1034-40.
4. Nikolovski J, Gulari E, Humes HD. Design engineering of a bioartificial renal tubule cell therapy device. Cell Transplant 1999; 8: 351-64. (Pubitemid 29409602)
5. Gueler F, Rong S, Park JK, et al. Postischemic acute renal failure is reduced by short-term statin treatment in a rat model. J Am Soc Nephrol 2002; 13: 2288-98. (Pubitemid 34925239)
6. Jao HC, Lin YT, Tsai LY, Wang CC, Liu HW, Hsu C. Early expression of heme oxygenase-1 in leukocytes correlates negatively with oxidative stress and predicts hepatic and renal dysfunction at late stage of sepsis. Shock 2005,23: 464-9. (Pubitemid 40571671)
7. Hu S, Sheng ZY, Zhou BT, et al. Study on delay two-phase multiple organ dysfunction syndrome. Chin Med J (Engl) 1998; 111: 101-18. (Pubitemid 128515253)
8. Tiranathanagul K, Brodie J, Humes HD. Bioartificial kidney in the treatment of acute renal failure associated with sepsis. Nephrology (Carlton); 2006; 11: 285-91. (Pubitemid 44102136)
9. Brendolan A, D'Intini V, Ricci Z, et al. Pulse high volume hemofiltration. Int J Artif Organs 2004; 27: 398-403.
10. Kendirli T, Ekim M, Ozçakar ZB, et al. Renal replacement therapies in pediatric intensive care patients: experiences of one center in Turkey. Pediatr Int 2007; 49: 345-8. (Pubitemid 46802301)
11. Eachempati SR, Wang JC, Hydo LJ, Shou J, Barie PS. Acute renal failure in critically ill surgical patients: persistent lethality despite new modes of renal replacement therapy. J Trauma 2007; 63: 987-93. (Pubitemid 350098514)
12. Ozgen N, Terashima M, Aung T, et al. Evaluation of long-term transport ability of a bioartificial renal tubule device using LLC-PK1 cells. Nephrol Dial Transplant 2004; 19: 2198-207. (Pubitemid 39214111)
13. Sweeney KJ, Kell MR, Coates C, Murphy T, Reynolds JV. Serum antigen(s) drive the proinflammatory T cell response in acute pancreatitis. Br J Surg 2003; 90: 313-9. (Pubitemid 36324110)
14. Schaeffer V, Cuschieri J, Garcia I, et al. The priming effect of C5a on monocytes is predominantly mediated by the p38 MAPK pathway. Shock 2007; 27: 623-30. (Pubitemid 46788161)
15. Kevin NC, Daniel GB, Eleanor MR. IL-10: The Master Regulator of Immunity to Infection. J Immunol 2008; 180: 5771-7.
16. Schneider CP, Schwacha MG, Chaudry IH. The role of interleukin- 10 in the regulation of the systemic inflammatory response following trauma-hemorrhage. Biochim Biophys Acta 2004; 1689: 22-32. (Pubitemid 38670499)
17. Loisa P, Rinne T, Laine S, Hurme M, Kaukinen S. Anti-in- flammatory cytokine response and the development of multiple organ failure in severe sepsis. Acta Anaesthesiol Scand 2003; 47: 319-25. (Pubitemid 36384671)
18. Malleo G, Mazzon E, Genovese T, et al. Absence of endogenous interleukin-10 enhanced organ dysfunction and mortality associated to zymosan-induced multiple organ dysfunction syndrome. Cytokine 2008; 41: 136-43.
19. Latifi SQ, O'Riordan MA, Levine AD. Interleukin-10 controls the onset of irreversible septic shock. Infect Immun 2002; 70: 4441-6.
20. Ferrer TJ, Webb JW, Wallace BH, et al. Interleukin-10 reduces morbidity and mortality in murine multiple organ dysfuntion syndrome (MODS). J Surg Res 1998; 77: 157-64.
21. Kielar M, Jeyarajah DR, Lu CY. The regulation of ischemic acute renal failure by extrarenal organs. Curr Opin Nephrol Hypertens 2002; 11: 451-7. (Pubitemid 34734626)
22. Humes HD, MacKay SM, Funke AJ, Buffington DA. Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics. Kidney Int 1999; 55: 2502-14.
23. Weber NC, Kandler J, Schlack W, Grueber Y, Frädorf J, Preckel B. Intermitted pharmacologic pretreatment by xenon, isoflurane, nitrous oxide, and the opioid morphine prevents tumor necrosis factor alpha-induced adhesion molecule expression in human umbilical vein endothelial cells. Anesthesiology 2008; 108: 199-207. (Pubitemid 351156729)
24. Zhou Z, Gengaro P, Wang W, et al. Role of NF-kappaB and PI 3-kinase/Akt in TNF-alpha-induced cytotoxicity in microvascular endothelial cells. Am J Physiol Renal Physiol 2008; 295: F932-41.
25. Burek M, Förster CY. Cloning and characterization of the murine claudin-5 promoter. Mol Cell Endocrinol 2009; 298: 19-24.